Grups J W
Urologische Klinik, Universität Würzburg.
Urologe A. 1988 Nov;27(6):348-51.
Between 1969 and March 1988, 257 patients underwent radical prostatectomy at the Department of Urology at the University of Würzburg, Medical School. The operative mortality was 0.8%. So far, 75 patients with prostate carcinoma, stage pT1-3 pNoMo, have been followed up for more than 10 years (mean 13 years). The 10-year survival rate was 68%. This is equivalent to the expected survival rate of males of comparable age. Only 14 of the 75 patients (18.6%) died of tumor progression after radical prostatectomy. Tumor recurrence was noted in 17 of the 75 (22.6%) patients analyzed within a 10-year follow-up period. In 4 of 9 patients with periprostatic tumor infiltration (stage pT3NoMo) tumor progression occurred. These data demonstrate that radical prostatectomy offers an excellent survival rate for patients with localized prostatic cancer and that this rate is identical to the expected survival rate for males in this age group.
1969年至1988年3月期间，维尔茨堡大学医学院泌尿外科对257例患者实施了根治性前列腺切除术。手术死亡率为0.8%。迄今为止，75例pT1-3 pNoMo期前列腺癌患者已接受了超过10年（平均13年）的随访。10年生存率为68%。这与同龄男性的预期生存率相当。75例患者中只有14例（18.6%）在根治性前列腺切除术后死于肿瘤进展。在10年随访期内分析的75例患者中有17例（22.6%）出现肿瘤复发。9例前列腺周围肿瘤浸润（pT3NoMo期）患者中有4例发生肿瘤进展。这些数据表明，根治性前列腺切除术为局限性前列腺癌患者提供了出色的生存率，且该生存率与该年龄组男性的预期生存率相同。
